Down‐regulation of transforming growth factor‐α by tamoxifen in human breast cancer

Cancer

Volumn 72, Issue 1, 1993, Pages 131-136

  Noguchi, Shinzaburo ^a   Motomura, Kazuyoshi ^a   Inaji, Hideo ^a   Imaoka, Shingi ^a   Koyama, Hiroki ^a  

^a CENTER FOR ADULT DISEASES   (Japan)

Author keywords

breast cancer; estrogen receptor; progesterone receptor; tamoxifen; transforming growth factor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TAMOXIFEN; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; ASPIRATION BIOPSY; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN CELL; POSTMENOPAUSE; PRIORITY JOURNAL;

BIOPSY, NEEDLE; BREAST; BREAST NEOPLASMS; DOWN-REGULATION; FEMALE; HUMAN; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TAMOXIFEN; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 0027325188     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19930701)72:1<131::AID-CNCR2820720125>3.0.CO;2-Z     Document Type: Article

References (24)

1. Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors
2. Rat transforming growth factor type I: structure and relation to epidermal growth factor
3. Transforming growth factor alpha
4. Transforming growth factor alpha: a more potent angiogenic mediator than epidermal growth factor
5. Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance
6. Regulation of proliferation, invasion, and growth factor synthesis in breast cancer by steroids
7. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
8. The pharmacology and clinical uses of tamoxifen
9. Characterization of estrogen responsive transforming activity in human breast cancer cell lines
10. Regulation of transforming growth factor alpha and transforming growth factor alpha messenger ribonucleic acid abundance in T47D human breast cancer cells
11. Epidermal and transforming growth factor alpha in patients with breast tumors
12. Inability of medroxyprogesterone acetate to down regulate estrogen receptor level in human breast cancer
13. Estrogen and progesterone receptor assays, by the EIA method (Abbott), of low‐speed supernates of breast cancer homogenates
14. Immunoreactive transforming growth factor alpha is commonly present in colorectal neoplasia
15. A simple, rapid, and sensitive DNA assay procedure
16. Pretranslational enhancement of epidermal growth factor receptor gene expression by direct effect of androgen in mouse liver
17. The attractions of proteins from small molecules and ions
18. Enzyme immunoassay of estrogen receptors in fine needle aspirates of breast tumors
19. International comparisons concerning breast cancer and steroid receptors
20. Endocrine therapy for advanced carcinoma of the breast: relationship between the effect of tamoxifen upon concentrations of progesterone receptor and subsequent response to tamoxifen
21. Comparison of monoclonal antibodies and tritiated ligands for estrogen receptor assays in 241 breast cancer cytosols
22. Epidermal growth factor receptor status as predictor of early recurrence of and death from breast cancer
23. Mechanisms of 4‐hydroxytamoxifen antigrowth factor activity in breast cancer cells: alterations of growth factor receptor binding sites and tyrosine kinase activity
24. Evidence that TGF‐beta is a hormonally regulated negative growth factor in human breast cancer